GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 118.67 billion as of February 27, 2026. Its market cap has decreased by -6.95% in one year.

Market Cap

118.67B

Enterprise Value

112.03B

Revenue

62.07B

Ranking

n/a

PE Ratio

12.92

Stock Price

372.62

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 118.67B, an increase of 3,046.97%. That is a compound annual growth rate of 11.59%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	118.67B	-4.40%
Dec 31, 2025	124.13B	-1.80%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	102.55B
AGP Limited	62.48B
The Searle Company	55.63B
Highnoon Laboratories	50.29B
Citi Pharma	19.30B
Ferozsons Laboratories	18.10B
Macter International	14.54B
Otsuka Pakistan	4.86B

Market Cap Rankings